Nucletron unveils brachytherapy, external beam treatment planning

Manjula Puthenedam, PhD, | | Health Imaging | Oncology Imaging
Nucletron will be releasing Oncentra, multi-modality treatment planning system for brachytherapy and external beam treatment, during the fourth quarter.

Oncentra v4.0 premieres a graphics processor unit calculation capability and features a new plan manager module that automates tasks during treatment planning with a new applicator-modeling feature, according to Nucletron, which is headquartered in Veenendaal, the Netherlands.

The company also said its Oncentra v4.0 will be on display and available for demonstration during the American Association of Physicists in Medicine annual meeting in Philadelphia this week.

Manjula Puthenedam, PhD,

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.